Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Financials Score | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | $4.53B | 1.60% | 1.50% | 1.64% | 3.20% | 0.05 | 17.77 | 93.90% | 21.60% | 25.44% | |
| TGTX | TG THERAPEUTICS INC | $2.54B | 12.90% | 4.70% | 9.31% | 12.00% | 1.05 | 5.92 | 94.00% | 5.40% | 10.99% | |
| SRPT | SAREPTA THERAPEUTICS INC | $12.35B | 2.00% | 0.50% | 1.30% | 1.00% | 2.36 | 4.05 | 88.20% | 1.20% | 2.43% | |
| CORT | CORCEPT THERAPEUTICS INC | $2.61B | 24.20% | 19.60% | 21.67% | 34.30% | 0.20 | 5.18 | 98.50% | 22.40% | 23.13% | |
| GMAB | GENMAB A | $18.33B | 17.60% | 15.70% | 23.76% | 41.70% | 0.13 | 12.46 | 97.70% | 30.70% | 45.37% | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.80B | 28.30% | 17.20% | 30.75% | 53.30% | 0.64 | 3.11 | 79.30% | 22.30% | 34.50% | |
| INCY | INCYTE CORP | $11.92B | 14.70% | 11.20% | 17.79% | 53.00% | 0.32 | 3.47 | 93.10% | 19.80% | 27.10% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $15.91B | 4.20% | 3.00% | 4.40% | 4.50% | 0.36 | 2.74 | 79.20% | 8.30% | 10.30% | |
| HALO | HALOZYME THERAPEUTICS INC | $5.05B | 204.80% | 15.80% | 22.65% | 17.70% | 19.68 | 6.64 | 76.80% | 34.00% | 44.27% | |
| RPRX | ROYALTY PHARMA PLC | $17.18B | 11.50% | 6.80% | 8.15% | 6.20% | 0.62 | 7.90 | 100.00% | 48.20% | 56.15% | |
| VNDA | VANDA PHARMACEUTICALS INC | $269.28M | 0.50% | 0.40% | 1.13% | 2.00% | 0.19 | 4.94 | 92.30% | 1.30% | 3.29% | |
| AMLX | AMYLYX PHARMACEUTICALS INC | $135.56M | 12.40% | 10.70% | 12.47% | 22.80% | 0.19 | 5.66 | 93.30% | 12.90% | 14.26% | |
| EXEL | EXELIXIS INC | $6.44B | 8.90% | 6.90% | 10.64% | 10.90% | 0.32 | 3.47 | 95.70% | 11.10% | 14.00% | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.89B | 9.20% | 2.90% | 5.32% | 7.30% | 2.06 | 2.27 | 89.50% | 8.60% | 13.51% | |
| TECH | BIO-TECHNE CORP | $11.88B | 11.50% | 8.40% | 10.12% | 18.30% | 0.39 | 4.37 | 67.10% | 19.60% | 22.94% | |
| PBYI | PUMA BIOTECHNOLOGY INC | $239.26M | 35.40% | 7.20% | 25.79% | 28.50% | 3.20 | 1.46 | 73.40% | 6.80% | 13.20% | |
| BNTX | BIONTECH SE | $21.93B | 4.60% | 4.20% | 5.78% | 16.10% | 0.14 | 9.43 | 84.30% | 24.40% | 31.68% | |
| MDXG | MIMEDX GROUP INC | $1.11B | 103.30% | 35.90% | 25.77% | 43.20% | 0.42 | 3.29 | 83.50% | 22.20% | 13.82% | |
| CPRX | CATALYST PHARMACEUTICALS INC | $1.77B | 19.80% | 16.50% | 23.98% | 190.70% | 0.21 | 2.88 | 86.90% | 17.90% | 23.73% | |
| NVO | NOVO NORDISK A S | $559.33B | 91.80% | 29.90% | 84.19% | 133.20% | 2.02 | 0.70 | 84.60% | 36.60% | 45.95% | |
| REGN | REGENERON PHARMACEUTICALS INC | $103.31B | 15.10% | 11.80% | 13.36% | 14.40% | 0.27 | 5.27 | 86.30% | 29.40% | 31.40% | |
| UTHR | UNITED THERAPEUTICS CORP | $11.45B | 18.70% | 15.40% | 25.55% | 25.60% | 0.22 | 3.78 | 88.90% | 42.00% | 57.63% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $103.36B | 22.60% | 17.30% | 23.06% | 69.80% | 0.29 | 3.99 | 87.20% | 36.70% | 44.83% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.